Cite
MLA Citation
Désirée van der Heijde et al.. “Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial.” Annals of the rheumatic diseases, vol. 81, no. 11, 2022, pp. 1515–1523. http://access.bl.uk/ark:/81055/vdc_100167911028.0x000061